![]() | |
Clinical data | |
---|---|
Other names | TVB-2640 |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C27H29N5O |
Molar mass | 439.563 g·mol−1 |
3D model (JSmol) | |
| |
|
Denifanstat (TVB-2640) is a small-molecule drug and fatty acid synthase inhibitor. Developed by Sagimet Biosciences, it has been tested in various types of cancer [1] [2] [3] [4] and for non-alcoholic steatohepatitis. [5]